Skip to main content

Evofem Biosciences, Inc.

EVFM
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001618835

No open-market purchases or sales by Evofem Biosciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Superinvestors holding EVFM, Q2 2026

See all superinvestors

No superinvestor reported holding EVFM in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of EVFM each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q2 2021

    0 superinvestors holding at quarter end

    Sold out
    Soros Fund Management